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 The aging process of the eye lens is associated with many
posttranslational protein modifications, including the forma-
tion of irreversible cross-linked protein aggregates, which are
believed to contribute to cataract formation [1-5]. The
proteasome is the major cellular proteolytic machinery respon-
sible for the selective elimination of damaged proteins, thus
preventing or delaying the accumulation of cross-linked pro-
tein aggregates. Lens fibers and lens epithelia have been dem-
onstrated to have a completely functional ubiquitin-proteasome
pathway, which can selectively eliminate oxidized proteins
[6,7]. An important factor that may contribute to the accumu-
lation of cross-linked protein aggregates is the decrease in
proteasome activity observed in aging lenses [8,9]. Although
some initial studies have indicated no correlations between
proteasome activity and age in human lenses [9], a more broad
age range study demonstrated that aging of the human lens is
accompanied by a decline in proteasome activity [8]. This age-
related decline in proteasome function has been correlated with
cataract formation and is thought to contribute to the accumu-
lation of carboxymethylated and ubiquitinated proteins ob-
served in elderly lenses [8]. While this decline in proteasome
activity affects preferentially trypsin-like and
peptidylglutamyl-peptide hydrolase activities in bovine lenses
[10], studies in human lenses showed that the decrease in
proteasome function with age is mainly associated with lower
levels of peptidylglutamyl-peptide hydrolase activity [8].
Despite the potential importance of enhancing the activ-
ity of the proteasome as a means to prevent the accumulation
of oxidized proteins and delay cataract formation, there is cur-
rently little information about the specific mechanisms by
which such an increase in proteasome activity can be accom-
plished and whether it actually has protective effects in lens
cells. Recent results conducted in human fibroblasts have
shown that overexpression of just one β-type subunit may be
sufficient to increase proteasome assembly and function.
Overexpression of either β5 or β1 alone will result in the co-
ordinated overexpression of the other two beta catalytic sub-
units, and the presence of β-type subunits leads to the recruit-
ment of free (nonintegrated) α subunits and an increased num-
ber of proteasomes assembled in the cells [11-15]. The in-
crease in proteasome activity that results from overexpression
of single β-type subunit has been shown to exert beneficial
effects by delaying cellular senescence and increasing cell
survival in response to oxidative stress [13-15].
Given the importance of understanding the role that the
age-related decline in proteasome function may have in cata-
ract formation, the objectives of this study were as follows:
(1) to determine whether the overexpression of the proteasome
catalytic β5 subunit (PSMB5) alone is sufficient to increase
the expression of the subunits β1 and β2 and enhance
proteasome activity in lens epithelial cells; and (2) to evaluate
the potential cytoprotective role of increased proteasome ac-
tivity in lens epithelial cells by measuring the effects on accu-
mulation of oxidized protein and cell survival following oxi-
dative stress.
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β2, increased CT-L and PGPH proteasome activities, and increased resistance to accumulation of carbonylated proteins
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subunit. The resulting increase in proteasome activity leads to a decrease in the accumulation of oxidized proteins and
enhanced cell survival following oxidative stress.
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31METHODS
Reagents and antibodies:  E. coli DH5α and the eukaryotic
expression plasmid pcDNA-3.1 were obtained from Invitrogen
(Carlsbad, CA). Oligonucleotide primers were synthesized by
Saibaisheng (Beijing, China). Restriction endonucleases
EcoRI, HindIII, and T4 ligase were obtained from TaKaRa
Bio Inc. (Osaka, Japan). Calf intestinal alkaline phosphatase
was purchased from Sangon Ltd (Shanghai, China). RT-PCR
analyses were performed using the One-step RT-PCR Kit
(Toyobo Bio-Technology, Shanghai, China). EndoFree Plas-
mid Maxi kit and lipofection SuperFect were purchased from
Qiagen (Valencia, CA). Antibodies against the proteosomal
subunits β5 (pw8895), β1 (pw8140), β2 (pw8145), and a-6
(pw8100) were purchased from Affinity Research Products
Ltd. (Mamhead Castle, United Kingdom). GAPDH antibody
was purchased from Kangcheng (Shanghai,China). The
fluorogenic substrates Suc-Leu-Leu-Val-Tyr-AMC (LLVY)
and Z-Leu-Leu-Glu-bNA (LLE) were obtained from Bachem
AG (Bubendorf, Swithland).
Human lens epithelial cell line SRA01/04 and culture con-
ditions:  Human lens epithelial cells (LEC), line SRA01/04,
was a generous gift from Dr. Fu Shang (Tufts university, Bos-
ton, MA) [16]. Cells were maintained at a density of 60%
confluence in 10 cm dishes at 37 °C in a humidified atmo-
sphere of 5% CO2 in Dulbecco’s modified eagle medium
(DMEM) supplemented with 15% fetal bovine serum (FBS),
L-glutamine (2 mM), penicillin (100 units/ml), and strepto-
mycin (0.1 mg/ml). All reagents were obtained from Gibco
(Grand Island, NY).
Construction of the eukaryotic expression plasmid
pcDNA3.1-PSMB5:  Total RNA was isolated from human LEC
(SRA01/04) using TRIzol reagent (Invitrogen Life Technolo-
gies). The human PSMB5 coding region sequence was then
amplified with the one-step RT-PCR kit (Toyobo Biotechnol-
ogy, Shanghai, China) using the following specific primers
designed according to the PSMB5 sequence gene (NCBI,
Unigene Hs.422990). Forward: 5'-GCG AAG CTT ATG GCG
CTT GCC AGC GTG T-3', and Reverse: 5'-AGA GAA TTC
TCA GGG GGT AGA GCC ACT AT-3', which contain the
restriction sites for HindIII and EcoRI, respectively. The PCR
amplification conditions were: predenaturation at 94 °C for 4
min, followed by 35 cycles of denaturation at 94 °C for 30 s,
annealing at 57 °C for 30 s, polymerization at 68 °C for 50 s at
68 °C, and a last polymerization cycle at 68 °C for 10 min.
The PCR product was analyzed in 1% agarose gel, purified,
and digested with HindIII and EcoRI. The digested fragment
was introduced into the HindIII/EcoRI sites in the eukaryotic
expression vector pcDNA3.1(+) by T4 ligation. The obtained
pcDNA3.1-PSMB5 plasmid was identified by restriction map-
ping and further confirmed by DNA sequencing analysis.
Overexpression of PSMB5 in lens epithelial cells:  To
overexpress the PSMB5, LECs were transfected with 2 mg of
the recombinant plasmid pcDNA3.1-PSMB5 using SuperFect
transfection reagent (Qiagen), following the manufacturer’s
instructions. A pcDNA3.1 empty plasmid was employed as a
negative control. Two days after transfection, G418 (700 µg/
ml) was added to the culture media for positive selection. Three
colonies of stable transfectants were isolated following three
to four weeks and propagated into cell lines.
Immunoblot analysis of proteasomal subunits expression:
The expression of β5 subunit as well as several representative
20S proteasomal subunits (β1, β2, and β6) in stably trans-
fected LECs was examined by western blot analysis. Briefly,
cell pellets were resuspended in a lysis buffer (50 mM Tris-
HCl, 150 mM NaCl, 1% NP-40, 0.1% SDS, and 1 mM PMSF),
incubated on ice for 30 min with occasional vortexing, and
clarified by centrifugation at 10,000x g for 10 min at 4 °C.
Protein concentration was quantified by Bio-Rad Protein As-
say (Bio-Rad Laboratories, Hercules, CA). Samples contain-
ing equal amounts of protein were resuspended in Laemmli
buffer, separated electrophoretically by SDS-PAGE (12%
gels), and subsequently transferred to polyvinylidene difluoride
(PVDF) membrane. Following transfer, membranes were
blocked for 1 h in PBS/Tween (0.01 M PBS with 0.1% Tween-
20) containing 5% (w/v) nonfat milk powder. After washing,
blots were incubated overnight at 4 °C with the appropriate
specific primary antibodies diluted in PBS/Tween containing
5% bovine albumin. The membranes were then washed and
incubated in the presence of horseradish peroxidase-conjugated
secondary antibodies for 60 min at room temperature. Immu-
noreactive bands were detected by enhanced chemilumines-
cence using the ECL plus kit (Amersham, San Francisco, CA).
Proteasome catalytic activities:  Proteasome activity was
determined by following the method described by Hosler et
al.[17]. Briefly, cells were harvested at 80-90% confluence
and centrifuged (400x g for 5 min) into pellets. After three
washes with PBS, cell pellets were lysed in proteasome activ-
ity buffer (10 mM Tris-HCl, pH 8.0; 1 mM DTT, and 0.2%
Nonidet P40) and the concentration adjusted to 1 µg/µl. The
proteasomal chymotrypsin-like activity (CT-L) and the
peptidylglutamyl-peptide hydrolase activity (PGPH) were
determined using the fluorogenic peptide substrates Suc-Leu-
Leu-Val-Tyr-AMC (LLVY) and Z-Leu-Leu-Glu-bNA (LLE),
respectively. The samples mixed with peptide substrates were
incubated at room temperature for 10 min. Fluorescence in-
tensities were monitored at 340 nm excitation and 440 nm
emission.
Protein oxidation analysis:  Levels of protein oxidation
were determined by spectrophotometric
dinitrophenylhydrazone (DNPH) assay, based on the detec-
tion of protein carbonyl residues derivatized with 2,4-
dinitrophenyl hydrazine (Sigma, St. Louis, MO) as described
in Niwa et al. [18]. Cells were lysed in 50 mM Tris-HCl, 150
mM NaCl, 1% NP-40, 0.1% SDS, and 1 mM PMSF. Lysed
cells were then clarified by centrifugation at 10,000x g at 4 °C
for 10 min and precipitated with cold trichloroacetic acid (TCA,
20% final concentration). A solution of 10 mM DNPH in 2N
HCl was added to the protein pellets to yield a final protein
concentration of 1-2 mg/ml. Next, 2N HCl was added to blanks.
Samples were incubated in the dark at room temperature for 1
h with vortexing every 10 min, followed by precipitation with
10-20% TCA. Protein pellets were washed three times with 1
ml of ethanol/ethyl acetate (1:1, v/v) to remove free DNPH.
Samples were then resuspended in 6N guanidine hydrochlo-
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32ride at 37 °C for 15 min by shaking and were measured by
spectrophotometry at 370 nm. Carbonyl contents were then
calculated in nmol/mg using the formula of Reznick and Packer
[19].
Cell viability assays:  Cell viability was determined as a
function of mitochondrial activity using 3-[4,5dimethylthiazol-
2-yl]-2,5-diphenyltetrazolium bromide substrate (MTT,
Sigma). Briefly, human LECs (5x104) stably transfected with
either empty vector or pcDNA3.1-PSMB5 plasmid were
seeded in 96-well plates and incubated for 24 h. Culture me-
dia was removed and cells were then incubated for 4 h in phe-
nol red-free serum-free DMEM (180 µl) containing the ap-
propriate concentration of H2O2. 20 µl MTT solution (5 mg/
ml in PBS) were added to each well, and cells were further
incubated for 4 h at 37 °C in 5% CO2. After this incubation
period, the culture media was replaced with 150 µl of DMSO.
The plate was subjected to gentle agitation for 15 min, and the
absorbance was read at 570 nm with a reference wavelength
of 630 nm. Each experiment was repeated three times. and
each data point in each experiment was the average of two
readings.
Apoptosis assays:  Apoptosis was assayed by flow
cytometry as described in the following references [20,21].
Cells were incubated in serum-free, phenol red-free DMEM
in the absence or in the presence of H2O2 (40 µM H2O2 was
added at single dose) at 37 °C for 24 h. After this period of
time, cells were harvested by trypsin digestion, resuspended
in one ml of hypotonic propidium iodide (PI) working solu-
tion (50 µg/ml PI, 1 g/l sodium citrate, 1 g/l Triton X-100),
and incubated overnight at 4 °C. Samples were analyzed in a
BD FACS Aria™ system (Becton Dickinson Biosciences, San
Jose, CA). In parallel experiments, nuclear damage was visu-
alized by Hoechst 33342 staining [22].
Statistical analysis:  The data was analyzed using a paired
Student’s t-test. Differences were considered statistically sig-
nificant only for p values lower than 0.05. All values were
expressed as mean±SD.
RESULTS
Overexpression of the proteasome β5 subunit in LECs induces
the expression of proteasome βsubunit:  Three independent
clones transfected with either the pcDNA3.1-PSMB5 or with
an empty plasmid were propagated into cell lines. These cell
lines did not exhibit any obvious differences in growth rate
and morphological characteristics compared to the parental
cells. All data and figures presented in the results are repre-
sentative of all three lines. Overexpression of proteasome β5
subunit in LECs stably transfected with pcDNA3.1-PSMB5
plasmid compared to controls transfected with an empty plas-
mid was confirmed by western blot analysis (Figure 1).
Overexpression of PSMB5 also resulted in a concomitant in-
crease in the expression of the subunits β1 and β2, but did not
exert any apparent effect on the expression of the α6 subunit
(Figure 1).
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Figure 1. Western blot analysis confirming the overexpression of β5
subunit in LECs stably transfected with PSMB5 plasmid compared
to control cells transfected with an empty plasmid.  Cells stably trans-
fected with the pcDNA3.1-PSMB5 plasmid also showed increased
expression of the catalytic subunits β1 and β2, while expression of
the constitutive subunit α6 subunit did not show any significant
change. GAPDH was used as a control. This figure is representative
of the three independent cell lines analyzed.
Figure 2. Effects of stable expression of the β5 proteasome subunit
on chymotrypsin-like and peptidyl glutamyl-peptide hydrolase cata-
lytic activities in LECs.  Mean values of activity were calculated as
percentage of activity compared to the control cells. Both proteasome
chymotrypsin-like (CT-L) catalytic activity (157.34±6.03%) and
proteasome peptidyl glutamyl-peptide hydrolase (PGPH) catalytic
activity (132.00±17.11%) were significantly increased in PSMB5
transfected cells as compared with the control cells. Each column
shows the average of three independent experiments (%). Similar
results were obtained in the three independent cell lines analyzed.
33Overexpression of the proteasome β5 subunit in LECs
results in an increase of proteasome activity:  LECs cells
overexpressing PSMB5 were used to investigate the effects
of the overexpression of this proteasome subunit on the chy-
motrypsin-like activity (CT-L) of the proteasome, which is
mediated by the β5 subunit, as well as on the peptidylglutamyl-
peptide hydrolase activity (PGPH), the proteasome activity
that shows a larger decrease with age in the lens and is depen-
dent on the catalytic subunit β1. Overexpression of the sub-
unit β5 resulted in a significant increase in both CT-L
(157.34±6.03%, p<0.05) and PGPH catalytic activities
(132.00±17.11%, p<0.05) as compared with the control cells
(Figure 2).
Overexpression of the proteasome β5 subunit decreases
the accumulation of protein oxidization following oxidative
stress:  Having established that overexpression of the β5 sub-
unit results in higher proteasome content and proteasome cata-
lytic activity, we investigated whether this “proteasome activ-
ity upregulation” could improve the ability of LECs to pre-
vent the accumulation of oxidized proteins after oxidative
stress. For this purpose, we treated PSMB5-transfected LECs
as well as its counterpart controls with 40 µM H2O2 and ana-
lyzed the presence of carbonyl residues resulting from protein
oxidation by spectrophotometric DNPH assay. Generally, car-
bonyl contents exist in LECs under normal culture conditions
[6]. Basal levels of carbonyl content measured prior to treat-
ment with H2O2 showed no significant difference between
LECs expressing PSMB5 and controls (0.41±0.10 nmol/mg
and 0.45±0.12 nmol/mg, respectively, p>0.05). When LECs
were exposed to 40 µM H2O2, carbonyl proteins increased dra-
matically both in LECs expressing PSMB5 and controls. How-
ever, this accumulation of oxidized proteins was significantly
lower in LECs expressing PSMB5 (1.63±0.36 nmol/mg ver-
sus 2.65±0.44 nmol/mg, p=0.036; Figure 3).
Overexpression of the β5 catalytic subunit in LECs leads
to increased survival after oxidative stress:  To evaluate the
potential cytoprotective effect of increased proteasome activ-
ity, we exposed LECs expressing PSMB5 and parallel con-
trols to different concentrations of H2O2 ranging from 10 to
100 mM. LEC cultures transfected with PSMB5 showed a
dose-dependent decrease in viability that was significantly
smaller than that of the control cell cultures, consistent with
an increase in the ability to cope with oxidative damage asso-
ciated with the expression of β5 (Figure 4). The highest levels
of differences in cell viability between PSMB5-expressing and
control cells were found at concentrations of 40 mM H2O2.
Expression of PSMB5 also resulted in an increase in re-
sistance to apoptosis after oxidative stress. Levels of apoptosis
were measured by flow cytometry with PI staining 24 h after
oxidative insult with 40 µM H2O2. The increase in apoptosis
induced by treatment with H2O2 was significantly lower in the
LECs expressing PSMB5 compared to the controls (controls:
15.7±1.9% versus 7.1±1.1%; PSMB5 expressing: 9.3±0.9%
versus 5.9±0.8%, p=0.0089; Figure 5). Similar to the apoptotic
profile observed by cell sorting, nuclear damage visualized
by Hoechst 33342 staining was also more accentuated in the
control cells compared to the β5 subunit expressing LECs (Fig-
ure 6).
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Figure 3. Effects of stable expression of the β5 proteasome subunit
on the accumulation of carbonylated proteins after H2O2 treatment in
LECs.  Basal level of carbonyl content measured prior to treatment
with H2O2 showed no significant difference between LECs express-
ing β5 subunit and controls (0.41±0.10 nmol/mg and 0.45±0.12 nmol/
mg, respectively, p>0.05). When LECs were exposed to 40 mM H2O2,
carbonyl content increased both in LECs overexpressing β5 and con-
trol cells. The accumulation of carbonyl proteins was significantly
lower in LECs expressing β5 (1.63±0.36 nmol/mg versus 2.65±0.44
nmol/mg, p<0.01). The result is representative of the three indepen-
dent cell lines analyzed.
Figure 4. Effects of stable expression of the β5 proteasome subunit
on the viability of LECs after H2O2 treatment.  Cell viability was
measured by the MTT method 4 h after addition of H2O2. Treatment
of LECs with H2O2 resulted in a dose-dependent decrease in viability
in both β5 expressing cells and nonexpressing controls. Stable ex-
pression of β5 resulted in a significant protective effect against H2O2
toxicity in LECs. Similar results were obtained in the three indepen-
dent cell lines analyzed.
34DISCUSSION
 The objective of this study was to evaluate the overexpression
of the proteasome subunit β5 in human LECs as a means to
increase, experimentally, proteasome function and, in particu-
lar, the PGPH activity, which has been shown to decline with
age in human lenses [8].
Studies on age-related alterations of proteasome pepti-
dase activities in different tissues have shown a similar de-
crease of PGPH activity in a variety of tissues [23-29]. The
reason for this age-related decrease in PGPH activity in hu-
man lens and other tissues is not clear yet. Proteasome sub-
units, similar to other proteins, may undergo oxidation reac-
tions that result in both structural and functional changes. It
has been suggested that preferential decline of PGPH activity
with age results from a higher susceptibility of the β1 subunit
to inactivation by oxidative processes [30]. Furthermore, cross-
linked proteins resulting either from prolonged oxidation or
from reactions with lipid peroxidation products, such as 4-
hydroxy-2-nonenal, have previously been reported to inhibit
the proteasome activity [31-35] and may also contribute to
the overall decline in proteasome function in the lens.
The proteasome is believed to play a major role in pre-
venting accumulation of damaged proteins in the lens; there-
fore identifying the means to modulate proteasome function
and revert the age-related decline in PGPH activity should
help to assess the relative importance of proteasome function
in cataract progression and evaluate the potential therapeutic
value for strategies based in proteasome upregulation.
One method that has been proven successful in generat-
ing an experimental increase in proteasome activity is the
overexpression of the β5 subunit. Overexpression of this sub-
unit in WI38/T and HL60 cells has been shown to elevate the
levels of other β-type subunits and increase all three
proteasome activities [11,12]. Functional studies have also
shown that overexpression of β5 confers enhanced survival
following oxidative stress that is associated with decreassed
accumulation of oxidized proteins [13-15].
Our results showed that overexpression of the β5 subunit
alone was sufficient to induce the expression of the subunits
β1 and β2 in LECs. These results are in concordance with
what has been reported in human fibroblasts and support that
there is a dependent regulation mechanism among the β-type
subunits. Although the mechanisms responsible for such co-
ordinated expression of β-subunits are not known, their exist-
ence is supported by a number of studies conducted in verte-
brate and invertebrate cells [14,15,36-41].
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Figure 5. Effects of stable expression of the β5 proteasome subunit on the levels of apoptosis in LECs after H2O2 treatment.  Frequency of
apoptotic cells before H2O2 treatment was 7.1±1.1% for control LECs (A) and 5.9±0.8% for LECs expressing β5 (B). Twenty-four h after
treatment with 40 mM H2O2, apoptotic cell frequency increased to 15.7±1.9% in control LECs (C) while LECs overexpressing the β5 proteasome
subunit experienced a smaller rise in apoptosis (9.3±0.9%; D). The flow cytometric measurements are representative of three independent
experiments.
35At the functional level, the coordinated expression of β1
and β2 subunits induced by the overexpression of β5 was re-
flected in the increase in CT-L and PGPH catalytic activities.
While CT-L activity is dependent on β5, PGPH activity is as-
sociated with the β1 subunit. The observed increase in PGPH
activity is particularly relevant, since this is the proteasomal
catalytic activity that experiences a more noticeable decline
with age in the human lens. Such increase in activity is ex-
pected to require the incorporation of β5 subunits into com-
plete proteasomes. Our results did not show any significant
effect of β5 overexpression on the levels of constitutive alpha
subunits. However, analysis by gel filtration has revealed a
higher level of proteasome assembly following expression of
β5 subunit in human fibroblasts that is directly linked to the
efficient integration of “free” (not integrated) α-type subunits
identified to accumulate in the cells [11-15]. There is also evi-
dence that the reported loss of proteasome function upon ag-
ing of several human tissues and senescent primary cultures is
due to lower levels of β-type subunits, which appear to be
“rate-limiting”, whereas α-type subunits remain in excess as
“free” subunits in senescent cells [11-15]. Therefore, synthe-
sis of additional α subunits may not be needed to assemble
new functional proteasomes following the increased expres-
sion of β5 and the concomitant increase in expression of β1
and β2 subunits. Other alternative explanations for the ob-
served increase in catalytic activity associated with
overexpression of the β5 subunit in absence of a concomitant
increase in the expression of α subunits are also possible. For
example, some proteasome subunits have been reported to act
as free monomers [42,43]. Given the complexity of the
proteasome maturation process and its regulation, the specific
mechanisms by which overexpression of β-5 might result in
an increase of proteasome activity and exert cytoprotective
effects will require further investigations to be fully clarified.
The phenotypic effects of overexpression of β5 in lens
cells included both: a significant decrease in the accumula-
tion of oxidized proteins and enhanced cell viability and sur-
vival after oxidative stress. These results emphasize the im-
portance of proteasome function as a defensive mechanism
against oxidative insults and support the concept that the ob-
served decline of proteasome functionality with age may be a
relevant contributing factor leading to cataract formation. Ac-
cumulation of abnormal proteins in the lens is not only deter-
mined by their rates of formation, but also by their rates of
elimination. Therefore, the rates of degradation of damaged
proteins by the proteasome may constitute a critical factor in
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Figure 6. Effects of stable expression of the β5 proteasome subunit on the nuclear morphology of LECs after H2O2 treatment.  Staining with
Hoechst 33342 revealed normal nuclear morphology in untreated LECs transfected with an empty plasmid (A) or with PSMB5 (B). After
treatment with 40 mM H2O2, the nuclei of control LECs showed more shrinking and fragmentation (D) than those from PSMB5-transfected
cells. Data is representative of three independent experiments.
36crosslinked protein accumulation and cataract formation. In-
creasing evidence supports the idea that the ability of the
proteasome to degrade oxidized proteins serves as a second-
ary cellular antioxidant defense system [44-47]. Consistent
with this notion, once the first line of defense constituted by
antioxidant mechanisms, such as the presence of reduced glu-
tathione, is over-run, the maintenance of proper protein struc-
ture and configuration in the lens may relay in the ability of
the proteasome system to selectively eliminate damaged pro-
teins and prevent their accumulation.
In conclusion, our results suggest that the proteasome can
be genetically “upregulated” in lens cells by over expression
of the β5 catalytic subunit, and the resulting increase in
proteasome activity enhances capacity of the cells to cope with
oxidative stress. Because the proteasome is down regulated
during the process of aging of the lens, the ability to experi-
mentally increase proteasome activity should be helpful to
study the relative importance of the age-related decline of
proteasome function in cataract formation and could poten-
tially lead to new therapeutic approaches to delay the progress
of this disease.
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